Benign Metastasizing Leiomyoma and Intravenous
Leiomyomatosis Following Total Hysterectomy:
Two Case Reports and a Literature Review
Volume 2 - Issue 3
Nathaniel A Parker DO1*, Christopher SR Dakhil MD2, Shaker R Dakhil MD2 and Daniel Lalich MD3
-
Author Information
Open or Close
- 1Resident Physician, University of Kansas School of Medicine Wichita, Wichita, USA
- 2Medical Oncologist, Cancer Center of Kansas, Wichita, USA
- 3Department of Pathology, Wesley Medical Center, Wichita, USA
*Corresponding author:
Nathaniel A Parker, Resident Physician, University of Kansas School of Medicine-Wichita, Wichita, USA
Received: July 11, 2018; Published: July 23, 2018
DOI: 10.32474/OAJOM.2018.02.000137
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
Uterine leiomyomas are the most common gynecological tumor in women of reproductive age. These tumors are typically
benign entities, but uncommonly transition toward tissues of malignant potential. Rare growth patterns of uterine leiomyomata have
been observed which include benign metastasizing leiomyoma (BML), disseminated peritoneal leiomyomatosis (DPL), intravenous
leiomyomatosis (IVL), retroperitoneal leiomyomatosis (RPL) and parasitic leiomyoma (PL). Metastasis of uterine fibroids most
commonly appear several years after the diagnosis and removal of uterine leiomyomata by hysterectomy. For two women who
sought treatment for BML and IVL in our clinic, we retrospectively outlined and
evaluated their specific genetic, pathological, and clinical features with the intention to
elucidate possible treatment options.
Abstract|
Introduction|
Case Reports|
Discussion|
Conclusion|
Acknowledgement|
References|